Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingemar Björkhem

Showing results (1-10 of 136) with videos related to

Pageof 14
Sort By:
Lipids|March 30, 2007
Rediscovery of cerebrosterolIngemar Björkhem
Current Opinion in Lipidology|June 14, 2013
Cerebrotendinous xanthomatosisIngemar Björkhem
The Journal of Clinical Investigation|September 18, 2002
Do oxysterols control cholesterol homeostasis?Ingemar Björkhem
Journal of Lipid Research|October 28, 2008
Are side-chain oxidized oxysterols regulators also in vivo?Ingemar Björkhem
Biochimie|November 1, 2012
Five decades with oxysterolsIngemar Björkhem
Biochemical and Biophysical Research Communications|May 25, 2010
Cerebrotendinous xanthomatosis: an inborn error in bile acid synthesis with defined mutations but still a challengeIngemar Björkhem, Magnus Hansson
Journal of Lipid Research|June 10, 2011
Still another activity by the highly promiscuous enzyme CYP3A4: 25-hydroxylation of cholesterolUlf Diczfalusy, Ingemar Björkhem
Arteriosclerosis, Thrombosis, and Vascular Biology|February 7, 2004
Brain cholesterol: long secret life behind a barrierIngemar Björkhem, Steve Meaney
Arteriosclerosis, Thrombosis, and Vascular Biology|May 15, 2002
Oxysterols: friends, foes, or just fellow passengers?Ingemar Björkhem, Ulf Diczfalusy
Journal of Neurology|November 30, 2019
Levels of 7alpha-hydroxycholesterol and/or 7alpha-hydroxy-4-cholest-3-one are the optimal biochemical markers for the evaluation of treatment of cerebrotendinous xanthomatosisDieter Lütjohann, Frans Stellaard, Ingemar Björkhem
Pageof 14

Showing results (1-10 of 136) with videos related to

Sort By:
Pageof 14
Lipids|March 30, 2007
Rediscovery of cerebrosterolIngemar Björkhem
Current Opinion in Lipidology|June 14, 2013
Cerebrotendinous xanthomatosisIngemar Björkhem
The Journal of Clinical Investigation|September 18, 2002
Do oxysterols control cholesterol homeostasis?Ingemar Björkhem
Journal of Lipid Research|October 28, 2008
Are side-chain oxidized oxysterols regulators also in vivo?Ingemar Björkhem
Biochimie|November 1, 2012
Five decades with oxysterolsIngemar Björkhem
Biochemical and Biophysical Research Communications|May 25, 2010
Cerebrotendinous xanthomatosis: an inborn error in bile acid synthesis with defined mutations but still a challengeIngemar Björkhem, Magnus Hansson
Journal of Lipid Research|June 10, 2011
Still another activity by the highly promiscuous enzyme CYP3A4: 25-hydroxylation of cholesterolUlf Diczfalusy, Ingemar Björkhem
Arteriosclerosis, Thrombosis, and Vascular Biology|February 7, 2004
Brain cholesterol: long secret life behind a barrierIngemar Björkhem, Steve Meaney
Arteriosclerosis, Thrombosis, and Vascular Biology|May 15, 2002
Oxysterols: friends, foes, or just fellow passengers?Ingemar Björkhem, Ulf Diczfalusy
Journal of Neurology|November 30, 2019
Levels of 7alpha-hydroxycholesterol and/or 7alpha-hydroxy-4-cholest-3-one are the optimal biochemical markers for the evaluation of treatment of cerebrotendinous xanthomatosisDieter Lütjohann, Frans Stellaard, Ingemar Björkhem
Pageof 14